Zanamivir Inhalation Powder Diskhaler from Canada
Relenza (zanamivir) is an inhaled antiviral powder for influenza treatment, delivered via Diskhaler device in measured doses. Classified in HTS 3004.90.92.06 as a transdermal-like system (inhalation) for anti-infective antiviral use.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Classify as drug-device combo; FDA 510(k) if applicable
• Protect from humidity; declare delivery system details